Preformulation Studies on Piperlongumine.

Area of Science:

• Pharmacology
• Pharmaceutical Sciences
• Natural Products Chemistry

Background:

• Piperlongumine is a natural alkaloid from piper plants with demonstrated in vitro anticancer activity.
• It shows higher cytotoxicity than established chemotherapeutics against breast, colon, and osteosarcoma cancers.
• However, its physicochemical properties remain poorly characterized, hindering formulation development.

Purpose of the Study:

• To conduct preformulation studies on piperlongumine.
• To identify factors influencing its solubility and stability for future drug formulation.
• To characterize degradation pathways and optimal conditions for piperlongumine.

Main Methods:

• Solubility assessment in aqueous media and with various excipients (surfactant, cosolvents, cyclodextrins).
• pH-stability profiling at different temperatures.
• Photostability testing under ultraviolet light exposure.

Main Results:

• Piperlongumine exhibits low aqueous solubility (approx. 26 μg/ml).
• Solubility significantly increased (27-fold) with 10% polysorbate 80; cosolvents and cyclodextrins yielded concentrations ≥ 1 mg/ml.
• Maximum stability observed around pH 4, with significant degradation at pH ≥ 7 and 3.
• Degradation of 10% expected in ~17 weeks at 25°C, pH 4.
• Marked photo-degradation occurred, especially in aqueous solutions.

Conclusions:

• Piperlongumine's poor solubility necessitates formulation strategies using surfactants, cosolvents, or cyclodextrins.
• Optimal stability is achieved at acidic pH (around 4), with instability at neutral and highly acidic/alkaline conditions.
• Piperlongumine is sensitive to light, requiring protective measures during formulation and storage.